Resource Logo
Miscellaneous News

HPV-related cancers rose before vaccines hit market




 

(Reuters Health) - The number of some cancers related to the human papillomavirus (HPV) increased throughout the U.S. before vaccines against the sexually transmitted infection were available, says to a new study.

Researchers found an increase in many early-stage cancers and anal and head and neck late-stage cancers across the U.S. between 1978 through 2007 that are thought to be related to the infection.

"Our findings support an important need for HPV vaccination given the absence of effective screening for tumors at these sites," Dr. George Kurdgelashvili, the study's lead author from the Oklahoma City Veterans Affairs Medical Center, told Reuters Health by email.

For the full article, click here.



 


Copyright © 2013 -Social Security Office, Publisher. All rights reserved to AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

Information in this article was accurate in May 9, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.